<DOC>
<DOCNO>
EP-0005174
</DOCNO>
<TEXT>
<DATE>
19791114
</DATE>
<IPC-CLASSIFICATIONS>
C07F-9/00 C07D-285/12 C07D-285/00 <main>C07D-285/12</main> C07F-9/6539 
</IPC-CLASSIFICATIONS>
<TITLE>
2-methyl-5-(2-hydroxystyryl)-1.3.4-thiadiazole and its preparation.
</TITLE>
<APPLICANT>
basf ag de<sep>basf aktiengesellschaft<sep>basf aktiengesellschaftcarl-bosch-strasse 3867063 ludwigshafende<sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
franke albrecht dr<sep>hagen helmut dr<sep>thieme peter c dr<sep>franke, albrecht, dr.<sep>hagen, helmut, dr.<sep>thieme, peter c., dr.<sep>franke, albrecht, dr.mandelring 11d-6706 wachenheimde<sep>hagen, helmut, dr.max-slevogt-strasse 17 ed-6710 frankenthalde<sep>thieme, peter c., dr.dr.-hans-hoffmann-strasse 5d-6706 wachenheimde<sep>franke, albrecht, dr.<sep>hagen, helmut, dr.  <sep>thieme, peter c., dr. <sep>franke, albrecht, dr.mandelring 11d-6706 wachenheimde<sep>hagen, helmut, dr.max-slevogt-strasse 17 ed-6710 frankenthalde<sep>thieme, peter c., dr.dr.-hans-hoffmann-strasse 5d-6706 wachenheimde<sep>
</INVENTOR>
<ABSTRACT>
The present invention relates to the 2-methyl-5- (2-hydroxystyryl) -1,3,4-thiadiazole of the formula and methods for its preparation by condensation of salicylaldehyde with 2.5-dimethyl-1,3,4-thiadiazole or2-methyl-5- (triphenylphosphine-methylene) -1,3,4-thiadiazole.The 2-methyl-5- (2-hydroxystyrylic) -1,3,4-thiadiazole represents a valuable intermediate for the preparation of pharmacologically active compounds, for example, the alkylamino-hydroxypropyl ether can be used as a medicament due to their Î²-sympatholytic effect as a medicament.Treatment of coronary heart disease, used by cardiac arrhythmias and hypertension.
</ABSTRACT>
</TEXT>
</DOC>
